This is a 3-year, labor-hour type contract awarded by the U.S. Food and Drug Administration (FDA), Office of Policy, Legislation and International Affairs (OPLIA) to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture. The $1,619,126.45 contract is for program support services, including medical and scientific writing, administrative support, information technology, quality assurance, database administration, and technical support. As an...
This is a $1,479,584.76 sole-source 8(a) contract awarded by the U.S. Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned and small disadvantaged business. The contract is for Freedom of Information Act (FOIA) support services for the FDA's Center for Biologics Evaluation and Research (CBER). As an 8(a) certified company, Aneon Brillient is able to obtain this single-award, labor-hour contract directly from the FDA without a competitive process. The contract has an...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture. The contract is for $164,005.68 to provide communications support services for the Immediate Office of the FDA Commissioner, with a period of performance through July 13, 2026. Aneon Brillient, LLC is a limited liability company based in Reston, Virginia that specializes in providing...
This is a $144,964.92 sole source 8(a) contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned small disadvantaged business. The contract is for additive manufacturing of medical products core facility support, on a labor-hour basis. Aneon Brillient is an SBA-certified 8(a) joint venture that specializes in providing professional services to the FDA, including across the Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation...
This is a definitive contract awarded by the U.S. Food and Drug Administration (FDA) to Aneon Brillient, LLC, a Small Business Administration (SBA) certified 8(a) joint venture, for $326,304.48. The contract provides shipping, receiving, printing support, and administrative support services for the FDA's Office of Regulatory Affairs Office of Training, Education, and Development (OTED). The contract is set aside for 8(a) small businesses and has a performance period ending on September 29, 2026....
This is a direct 8(a) sole source award of a 12-month base and 9-month option, labor hour type contract to Aneon Brillient, LLC for the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to provide professional services. The contract has a ceiling value of $4,277,014.63 and an ultimate completion date of May 31, 2026. Aneon Brillient is a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture. The company has a history of...
This is a direct 8(a) award of a 12-month, labor-hour type contract to Aneon Brillient, LLC for the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to provide professional services support. The contract has a ceiling value of $3,266,346.36 and does not utilize a set-aside. Aneon Brillient is a minority-owned, small disadvantaged business registered as an 8(a) joint venture that specializes in providing a range of professional services to the FDA,...
This is a 1-year, labor-hour (LH) type contract awarded to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture. The contract, valued at $191,129.18, is for quality management system services via a Quality Assurance Specialist III for the U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality. The contract was awarded as a direct 8(a) sole source. Aneon Brillient, LLC...
This is a $642,543.27 definitive contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, an 8(a) certified small disadvantaged business, to provide transcription services to support the Center for Drug Evaluation and Research (CDER) advisory committee meetings. The contract has a completion date of February 27, 2026 and is a sole source award under the 8(a) program. Aneon Brillient specializes in providing professional services to the FDA, including medical and...
This is a direct 8(a) sole source, labor-hour type contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an 8(a) joint venture. The contract is for professional services to support the FDA's Oncology Center of Excellence, with an ultimate completion date of August 11, 2026 and a ceiling value of $2,220,109.12. Aneon Brillient, LLC specializes in providing a variety of professional services to the FDA,...